Hepatic β-arrestin 2 is essential for maintaining euglycemia.
Saved in:
| Title: | Hepatic β-arrestin 2 is essential for maintaining euglycemia. |
|---|---|
| Authors: | Zhu L; Molecular Signaling Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Bethesda, Maryland, USA., Rossi M; Molecular Signaling Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Bethesda, Maryland, USA., Cui Y; Molecular Signaling Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Bethesda, Maryland, USA., Lee RJ; Molecular Signaling Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Bethesda, Maryland, USA., Sakamoto W; Molecular Signaling Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Bethesda, Maryland, USA., Perry NA; Department of Pharmacology, Vanderbilt University, Nashville, Tennessee, USA., Urs NM; Department of Cell Biology, Duke University Medical Center, Durham, North Carolina, USA., Caron MG; Department of Cell Biology, Duke University Medical Center, Durham, North Carolina, USA., Gurevich VV; Department of Pharmacology, Vanderbilt University, Nashville, Tennessee, USA., Godlewski G; Laboratory of Physiologic Studies, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland, USA., Kunos G; Laboratory of Physiologic Studies, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland, USA., Chen M; Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA., Chen W; Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA., Wess J; Molecular Signaling Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Bethesda, Maryland, USA. |
| Source: | The Journal of clinical investigation [J Clin Invest] 2017 Aug 01; Vol. 127 (8), pp. 2941-2945. Date of Electronic Publication: 2017 Jun 26. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
